Partners X. Llc Canaan serves as Executive at Protagonist Therapeutics, Inc, where they oversee executive responsibilities. Since joining the company, Partners X. Llc Canaan has executed 13 insider transactions totaling $10.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 31, 2021 involved transacting 4,200,000 shares valued at $0.
Partners X. Llc Canaan currently holds 16,489,668 shares of Protagonist Therapeutics, Inc (PTGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Partners X. Llc Canaan has been a net buyer of PTGX stock. They have purchased $7.0M and sold $3.2M worth of shares.
Partners X. Llc Canaan's most recent insider trade was on Dec 31, 2021, when they sold 4,200,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.09 |
| Discretionary |
| May 16, 2018 | PTGX | $190.2K | Sale | 29,441 | $6.46 | Discretionary |
| May 15, 2018 | PTGX | $374.0K | Sale | 57,715 | $6.48 | Discretionary |
| May 14, 2018 | PTGX | $494.3K | Sale | 77,591 | $6.37 | Discretionary |
| Mar 23, 2018 | PTGX | $1.2M | Sale | 59,950 | $20.71 | Discretionary |
| Mar 19, 2018 | PTGX | $276.4K | Sale | 13,439 | $20.57 | Discretionary |
| Mar 16, 2018 | PTGX | $142.1K | Sale | 6,926 | $20.51 | Discretionary |
| Mar 15, 2018 | PTGX | $242.5K | Sale | 11,751 | $20.64 | Discretionary |
| Mar 14, 2018 | PTGX | $4.2K | Sale | 200 | $20.77 | Discretionary |
| Mar 13, 2018 | PTGX | $25.1K | Sale | 1,204 | $20.84 | Discretionary |
| Aug 16, 2016 | PTGX | $0 | Conversion | 1,869,922 | $N/A | Discretionary |
| Aug 16, 2016 | PTGX | $7.0M | Purchase | 583,333 | $12.00 | Discretionary |